Page last updated: 2024-08-24

sparfloxacin and Atypical Mycobacterial Infection, Disseminated

sparfloxacin has been researched along with Atypical Mycobacterial Infection, Disseminated in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's5 (62.50)18.2507
2000's3 (37.50)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bentoucha, A; Dega, H; Grosset, J; Jarlier, V; Robert, J1
Bourgeois, P; Cambau, E; Desplaces, N; Dion, E; Dubourg, G; Koeger, AC; Robin, H; Roche, B; Rozenberg, S; Vergeron, H1
Andonegui, M; Martín-Casabona, N; Martínez, E; Royo, P1
Higashiyama, Y; Kohno, S; Maesaki, S; Miyazaki, Y; Tashiro, T; Tomiyama, Y; Tomono, K; Yong, B1
Adam, G; Haase, G; Riehl, J; Schmitt, H; Schnitzler, N; Sieberth, HG1
Kaur, D; Khuller, GK1
Everett, D; Gillespie, SH; Morrissey, I1
Kamisaka, K; Kawahara, S; Kibata, M; Konishi, H; Matsuyama, T; Mishima, Y; Shiomi, K; Tada, A; Takeuchi, M; Yoshimoto, S1

Other Studies

8 other study(ies) available for sparfloxacin and Atypical Mycobacterial Infection, Disseminated

ArticleYear
Bactericidal activity of rifampin-amikacin against Mycobacterium ulcerans in mice.
    Antimicrobial agents and chemotherapy, 2002, Volume: 46, Issue:10

    Topics: Amikacin; Animals; Anti-Bacterial Agents; Clarithromycin; Colony Count, Microbial; Disease Models, Animal; Drug Therapy, Combination; Female; Fluoroquinolones; Foot; Mice; Mice, Inbred BALB C; Mycobacterium Infections, Nontuberculous; Mycobacterium ulcerans; Rifampin; Skin Ulcer

2002
Efficacy of combined clarithromycin and sparfloxacin therapy in a patient with discitis: due to Mycobacterium xenopi.
    Revue du rhumatisme (English ed.), 1997, Volume: 64, Issue:1

    Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Discitis; Drug Therapy, Combination; Fluoroquinolones; Humans; Lumbar Vertebrae; Male; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Quinolones; Sacrum

1997
In vitro susceptibility of Mycobacterium kansasii to the difluorinated quinolone sparfloxacin using a broth microdilution and macrodilution MIC system.
    The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 1999, Volume: 3, Issue:4

    Topics: Anti-Infective Agents; Antitubercular Agents; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Mycobacterium Infections, Nontuberculous; Mycobacterium kansasii

1999
[The combination therapy of clarithromycin and sparfloxacin for pulmonary Mycobacterium gordonae infection].
    Kekkaku : [Tuberculosis], 1999, Volume: 74, Issue:5

    Topics: Aged; Anti-Infective Agents; Antitubercular Agents; Clarithromycin; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Pneumonia, Bacterial; Treatment Outcome

1999
Successful treatment of pulmonary Mycobacterium xenopi infection in a natural killer cell-deficient patient with clarithromycin, rifabutin, and sparfloxacin.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1999, Volume: 29, Issue:1

    Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Antitubercular Agents; Clarithromycin; Drug Therapy, Combination; Fluoroquinolones; Humans; Killer Cells, Natural; Lung; Male; Mycobacterium Infections, Nontuberculous; Mycobacterium xenopi; Rifabutin; Treatment Outcome; Tuberculosis, Pulmonary

1999
In vitro, ex-vivo and in vivo activities of ethambutol and sparfloxacin alone and in combination against mycobacteria.
    International journal of antimicrobial agents, 2001, Volume: 17, Issue:1

    Topics: Animals; Anti-Infective Agents; Antitubercular Agents; Colony Count, Microbial; Disease Models, Animal; Drug Interactions; Drug Therapy, Combination; Ethambutol; Fluoroquinolones; Mice; Microbial Sensitivity Tests; Mycobacterium avium; Mycobacterium Infections, Nontuberculous; Mycobacterium smegmatis; Mycobacterium tuberculosis; Tuberculosis

2001
A comparison of the bactericidal activity of quinolone antibiotics in a Mycobacterium fortuitum model.
    Journal of medical microbiology, 2001, Volume: 50, Issue:6

    Topics: Anti-Infective Agents; Aza Compounds; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Drug Resistance, Multiple; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Models, Biological; Moxifloxacin; Mycobacterium fortuitum; Mycobacterium Infections, Nontuberculous; Ofloxacin; Quinolines

2001
[A case of pulmonary atypical mycobacteriosis complicated with aplastic anemia, treated with surgical resection and postoperative sparfloxacin].
    Nihon Kyobu Shikkan Gakkai zasshi, 1992, Volume: 30, Issue:7

    Topics: Anemia, Aplastic; Anti-Infective Agents; Antitubercular Agents; Chemotherapy, Adjuvant; Combined Modality Therapy; Fluoroquinolones; Humans; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Pneumonectomy; Quinolones; Tuberculosis, Pulmonary

1992